U.S. clears AstraZeneca over heart drug trial
August 19, 2014 at 06:44 AM EDT
LONDON (Reuters) - The U.S. government has cleared AstraZeneca Plc over a major clinical trial used to win marketing approval for its important new heart drug Brilinta, following an investigation which had cast a shadow over its prospects.
